• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
RnRMR US Insulation Market to 2017
 

RnRMR US Insulation Market to 2017

on

  • 170 views

The report “Insulation to 2017” by Freedonia Group is now available at RnRMarketResearch.com. Contact sales@rnrmarketresearch.com with report name in subject line and your contact details to ...

The report “Insulation to 2017” by Freedonia Group is now available at RnRMarketResearch.com. Contact sales@rnrmarketresearch.com with report name in subject line and your contact details to purchase this report or get your questions answered.

US demand to rise 7.6% annually through 2017
US demand for insulation is projected to advance 7.6 percent annually to $10.3 billion in 2017. Growth will be driven by an increase in building construction spending from a low 2012 base. Gains will also be boosted by changes in building codes and construction practices that call for structures to use energy more efficiently. Such measures as the 2012 International Energy Conservation Code (IECC) and the most recent Leadership in Energy and Environmental Design set of codes — LEEDv4 — will spur construction professionals to add more insulation to reduce energy consumption.

Statistics

Views

Total Views
170
Views on SlideShare
170
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    RnRMR US Insulation Market to 2017 RnRMR US Insulation Market to 2017 Presentation Transcript

    • Insulation to 2017 by Freedonia Group Browse more reports on Construction Material Market @ http://www.rnrmarketresearch.com/reports/manufacturingconstruction/construction/construction-material . © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441
    • Insulation to 2017 The global is estimated to reach $2.0 billion by 2018 at a CAGR of more than 20% between 2013 and 2018. The biosimilar products market is segmented into recombinant non-glycosylated proteins, recombinant glycosylated proteins, and recombinant peptides. The recombinant non-glycosylated proteins market is further segmented as insulin, granulocyte colony-stimulating factor (G-CSF), interferons, and human growth hormone; whereas the recombinant glycosylated proteins market is further broken down into erythropoietin, monoclonal antibodies, and follitropin. Calcitonin and glucagon are considered in the recombinant peptides market. The recombinant glycosylated proteins segment is expected to witness the highest growth due to the increased demand for monoclonal antibodies in the treatment for cancer (oncology), autoimmune disorders, blood disorders, and infectious diseases. Oncology will be the fastest-growing segment and currently accounts for a 25% market share in the global market in 2013. Following monoclonal antibodies, biosimilars of insulin will be the fastest-growing products and are estimated to grow at aCAGR of 35.6% from 2013 to 2018. The growth is attributed to the rise in incidences of diabetes; ongoing patent expirations of biologic drugs such as Lantus, Humalog, and Novorapid; and the cost effectiveness of the biosimilars of insulin. Complete report available @ http://www.rnrmarketresearch.com/biosimilars-market-product-recombinant-nonglycosylated-proteins-insulin-filgrastim-somatropin-glycosylated-monoclonal-antibodies-erythropoietin-peptidesglucagon-calcitonin-applicatio-market-report.html . Other notable driving factors for the global market include increasing number of off-patented drugs, positive outcome in the ongoing clinical trials, and rising demand for biosimilars in different therapeutic applications such as rheumatoid arthritis and blood disorders Browse more reports on Construction Material Market @ http://www.rnrmarketresearch.com/reports/manufacturingconstruction/construction/construction-material . © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441
    • Insulation to 2017 Market dynamics analysis has identified that rising budgetary pressures to reduce healthcare expenditures, increasing aging population, growing demand for cost-effective alternatives, rising incidences of various diseases, and conducive government initiatives are significant factors propelling the market in the forecast period (2013 to 2018). On the other hand, stringent regulatory environment, high manufacturing complexities and costs, and highentry barriers are considered to hinder the market growth.Additionally, the different terminology and guidelines for biosimilars across regions will further burden the biosimilars industry. Generic versions of biologic drugs approved under the European Medical Agency (EMA) regulatory pathway and section 351K of the U.S. FDA are considered as biosimilars. In the U.S., biosimilars are also known as follow-on-proteins and have been approved under section 501(b), whereas in Canada, biosimilars are called Substituent Entry Biologics (SEB). Geographic analysis reveals that Europe is the largest contributor to the global market. Asia-Pacific (China, India, and South Korea), North America (U.S.), and Latin America (Brazil) are poised to grow at high double-digit rates. Request a sample copy @ http://www.rnrmarketresearch.com/contacts/requestsample?rname=130963 . The global market is highly consolidated with the top three players, namely, Sandoz (Germany), Hospira (U.S.), and Teva (Israel) accounting for approximately 90% of the market share. Other notable players in the market include Dr. Reddy’s Laboratories (India), Biocon Ltd. (India), Mylan (U.S.), Biopartners (Switzerland), Amgen (U.S.), and IntasBiopharmaceutical Ltd. (India). Browse more reports on Construction Material Market @ http://www.rnrmarketresearch.com/reports/manufacturingconstruction/construction/construction-material . © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441
    • Insulation to 2017 For more details contact Mr. Priyank Tiwari: sales@rnrmarketresearch.com / +18883915441 RnR Market Research RnRMarketResearch.com, an online repository of market research reports, offers in-depth analysis of over 5000 market segments. RnR Market Research library has syndicated reports by leading market research publishers across the globe. © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441